Psych360’s Psychotropic Consult Care-Path™ was established to help our clients manage psychotropic medications in their facility. Through implementation of CMS (Centers for Medicare & Medicaid Services) and ASCP (American Society of Consultant Pharmacists) recommended guidelines for psychotropic drug management we focus on regulatory adherence for these psychotropic medications and quality of life for patients. There is an important balance to target and strike and its important to have specialists familiar with these medications and their actions involved in this aspect of care.
With the initiation of the CMS Mega Rule, this mandates a Drug Regimen Review (DRR) monthly on each resident performed by the Pharmacist. Any recommendations regarding the patients drug regimen will need to be reviewed and addressed promptly. The new initiative has been expanded to encompass all psychotropic medications, not just anti-psychotics.
Any medication capable of affecting the mind, emotions, and behavior or medications that alter brain chemistry are considered psychotropic medications.
Classes of psychotropic medications include the following:
- Sedatives and Hypnotics
Our goal in collaboration with our clients interdisciplinary team is to reduce and/or limit pharmacologic interventions. However, when they are necessary a coordinated effort aligned with CMS and ASCP guidelines and state/federal regulations is the most appropriate and sound approach for both safety and optimizing quality of life for the patient. This is the goal of this program.